Simultaneous quantitation of atorvastatin and its two active metabolites in human plasma by liquid chromatography/(–) electrospray tandem mass spectrometry
Authors:
Open Access
- 1 February 2014
- journal article
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 4 (1) , 26-36
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Modifying conventional high-performance liquid chromatography systems to achieve fast separations with Fused-Core columns: A case studyJournal of Chromatography A, 2011
- Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatinJournal of Chromatography B, 2009
- Development and Validation of Atorvastatin by LC–ESI–MS and Application in Bioequivalence Research in Healthy Chinese VolunteersChromatographia, 2007
- AtorvastatinDrugs, 2007
- Matrix effects in quantitative pesticide analysis using liquid chromatography–mass spectrometryMass Spectrometry Reviews, 2006
- Clinical Pharmacokinetics of AtorvastatinClinical Pharmacokinetics, 2003
- Pharmacology of 3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and PitavastatinThe Journal of Clinical Pharmacology, 2002
- AtorvastatinDrugs, 2001
- AtorvastatinDrugs, 1997
- Tolerance and Pharmacokinetics of Single‐Dose Atorvastatin, a Potent Inhibitor of HMG‐CoA Reductase, in Healthy SubjectsThe Journal of Clinical Pharmacology, 1996